AMBROSIO, Maria Rosaria
 Distribuzione geografica
Continente #
NA - Nord America 508
EU - Europa 212
AS - Asia 59
AF - Africa 8
SA - Sud America 1
Totale 788
Nazione #
US - Stati Uniti d'America 503
IT - Italia 92
SE - Svezia 40
DE - Germania 24
KR - Corea 22
JP - Giappone 12
VN - Vietnam 11
GB - Regno Unito 6
CN - Cina 5
ES - Italia 5
FR - Francia 5
NL - Olanda 5
CA - Canada 4
CZ - Repubblica Ceca 4
GR - Grecia 4
HK - Hong Kong 4
IE - Irlanda 4
PL - Polonia 4
RS - Serbia 4
RU - Federazione Russa 4
MK - Macedonia 3
ZA - Sudafrica 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
DZ - Algeria 2
EG - Egitto 2
LV - Lettonia 2
BE - Belgio 1
CO - Colombia 1
HU - Ungheria 1
IN - India 1
MA - Marocco 1
ME - Montenegro 1
MX - Messico 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 788
Città #
Santa Cruz 62
Ferrara 42
Stockholm 40
Ashburn 38
Fairfield 38
Houston 27
Buffalo 25
Des Moines 20
Ann Arbor 16
Seattle 16
Bologna 15
Chicago 12
San Diego 12
Seongnam 12
Dong Ket 11
Los Angeles 10
Woodbridge 9
Boardman 8
Seoul 8
Cambridge 7
Berlin 6
Granarolo dell'Emilia e Viadagola 6
Longmont 6
Wilmington 6
Brooklyn 5
Dallas 5
Athens 4
Birmingham 4
Central 4
Chengdu 4
Denver 4
Dublin 4
Las Vegas 4
Provo 4
Rome 4
Warsaw 4
Boulder 3
Council Bluffs 3
Herndon 3
Miami 3
Muizenberg 3
Munich 3
New York 3
Providence 3
Toronto 3
Tourcoing 3
Adelfia 2
Algiers 2
Belgrade 2
Breda 2
Bremen 2
Chiba 2
Chiyoda-ku 2
Crugers 2
Córdoba 2
Genoa 2
Henderson 2
Lake Forest 2
Memphis 2
Milan 2
Phoenix 2
Portland 2
Presque Isle 2
Prilep 2
Rochester 2
Rosendaal 2
Saint Paul 2
Saint Petersburg 2
San Francisco 2
Shu 2
Solagna 2
Torpoint 2
Zurich 2
Alexandria 1
Auburn 1
Basking Ridge 1
Bengaluru 1
Brockport 1
Cairo 1
Cebu 1
Cedar Knolls 1
Clearwater 1
Daizawa 1
Dubai 1
Edison 1
Fallbrook 1
Ferrara di Monte Baldo 1
Frankfurt am Main 1
Fukuoka 1
Hamburg 1
Huntsville 1
Istanbul 1
Karcag 1
Karlsruhe 1
Kirkland 1
Kobe 1
Lincoln 1
Lombard 1
Madrid 1
McHenry 1
Totale 613
Nome #
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds, file e309ade0-26af-3969-e053-3a05fe0a2c94 193
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids, file e309ade4-7d55-3969-e053-3a05fe0a2c94 74
A tool to predict survival in stage IV entero-pancreatic NEN, file e309ade2-c6a9-3969-e053-3a05fe0a2c94 61
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids, file e309ade0-3375-3969-e053-3a05fe0a2c94 46
Lumbar spine mineral density Z-score discrepancy by DXA and QCT in thalassaemic major patients, file e309ade4-813a-3969-e053-3a05fe0a2c94 44
NEP-Score Thresholds Predict Survival of Patients With Bronchial Carcinoids, file e309ade3-ca32-3969-e053-3a05fe0a2c94 39
Neck paraganglioma and follicular lymphoma: A case report, file e309ade2-70c9-3969-e053-3a05fe0a2c94 34
Analysis of characteristics and outcomes by growth hormone treatment duration in adult patients in the Italian cohort of the Hypopituitary Control and Complications Study (HypoCCS), file e309ade2-1553-3969-e053-3a05fe0a2c94 33
Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience, file 766c09b2-a8ae-4fdb-90f1-849a16721718 28
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region, file e309ade0-8a6a-3969-e053-3a05fe0a2c94 28
Anterior pituitary function may predict functional and cognitive outcome in patients with traumatic brain injury undergoing rehabilitation., file e309ade1-47f6-3969-e053-3a05fe0a2c94 22
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame, file e309ade4-4e5f-3969-e053-3a05fe0a2c94 17
Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study., file e309ade1-45d4-3969-e053-3a05fe0a2c94 14
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria, file e4f85820-f75d-4a98-b524-0b5a0ef0e6e9 14
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients, file e309ade3-9f29-3969-e053-3a05fe0a2c94 13
Investigation of COVID‑19 infection in subjects with Klinefelter syndrome, file e309ade5-5850-3969-e053-3a05fe0a2c94 12
Hypeprolactinemia: still an insidious diagnosis, file e309ade2-b0fd-3969-e053-3a05fe0a2c94 9
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man, file e309ade0-21f1-3969-e053-3a05fe0a2c94 6
Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors, file e309ade1-4e23-3969-e053-3a05fe0a2c94 6
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man, file e309ade0-21f9-3969-e053-3a05fe0a2c94 5
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas, file e309ade0-3d3a-3969-e053-3a05fe0a2c94 5
Italian association of clinical endocrinologists (Ame) and italian aace chapter position statement for clinical practice: acromegaly part 2: Therapeutic issues, file e309ade3-a5e1-3969-e053-3a05fe0a2c94 5
X-linked acrogigantism syndrome: clinical profile and therapeutic responses, file e309ade3-ca0a-3969-e053-3a05fe0a2c94 5
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study., file e309ade0-26b1-3969-e053-3a05fe0a2c94 4
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke, file e309ade0-3376-3969-e053-3a05fe0a2c94 4
Real-world study of everolimus in advanced progressive neuroendocrine tumors, file e309ade0-405e-3969-e053-3a05fe0a2c94 4
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression, file e309ade0-4db6-3969-e053-3a05fe0a2c94 4
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C , file e309ade0-b7ea-3969-e053-3a05fe0a2c94 4
Valutazione dell’efficacia della terapia transdermica e iniettiva con testosterone nella Sindrome di Klinefelter: uno studio in real-life, file e309ade4-e5cf-3969-e053-3a05fe0a2c94 4
Hypeprolactinemia: still an insidious diagnosis, file 67ce3b9d-6bbf-4f21-8883-aaf459d729f1 3
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension, file e309ade0-21f7-3969-e053-3a05fe0a2c94 3
Systemic illness, file e309ade0-282d-3969-e053-3a05fe0a2c94 3
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion., file e309ade0-2d17-3969-e053-3a05fe0a2c94 3
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model., file e309ade0-3373-3969-e053-3a05fe0a2c94 3
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression., file e309ade0-33b5-3969-e053-3a05fe0a2c94 3
Progetto formativo acrofragile: impiego del metodo Delphi, file e309ade1-3fe5-3969-e053-3a05fe0a2c94 3
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame, file e309ade1-9541-3969-e053-3a05fe0a2c94 3
Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 1: Diagnostic and Clinical Issues, file e309ade3-a789-3969-e053-3a05fe0a2c94 3
Iperprolattinemia: vecchie e nuove insidie diagnostiche, file e309ade4-e5ce-3969-e053-3a05fe0a2c94 3
L’acromegalia nell’anziano, file e309ade5-3361-3969-e053-3a05fe0a2c94 3
Glucose Metabolism Derangements and Thyroid Nodules: Does Sex Matter?, file e309ade5-5b45-3969-e053-3a05fe0a2c94 3
Bariatric Surgery in a Case of Hypopituitary Patient with Craniopharyngioma: Management of Hypopituitarism and Long-Term Efficacy, file e309ade5-87ca-3969-e053-3a05fe0a2c94 3
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion., file e309ade0-249b-3969-e053-3a05fe0a2c94 2
In vitro testing of new somatostatin analogs on pituitary tumor cells, file e309ade0-27cc-3969-e053-3a05fe0a2c94 2
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization, file e309ade0-34f4-3969-e053-3a05fe0a2c94 2
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro, file e309ade1-47c5-3969-e053-3a05fe0a2c94 2
Predictive value of circulating insulin-like growth factor I levels in ischemic stroke outcome., file e309ade1-47fa-3969-e053-3a05fe0a2c94 2
Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas, file e309ade1-5478-3969-e053-3a05fe0a2c94 2
Long-term safety and efficacy of Omnitrope® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study, file e309ade1-a66b-3969-e053-3a05fe0a2c94 2
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients, file e309ade3-a9ea-3969-e053-3a05fe0a2c94 2
X-linked acrogigantism syndrome: clinical profile and therapeutic responses, file e309ade3-bac3-3969-e053-3a05fe0a2c94 2
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors, file e309ade5-584e-3969-e053-3a05fe0a2c94 2
GH/IGF-1 axis in a large cohort of ss-thalassemia major adult patients: a cross-sectional study, file e309ade5-6e26-3969-e053-3a05fe0a2c94 2
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance, file 1c2c9d58-57ee-476a-b19a-354fdeab1bc8 1
null, file e309ade0-302a-3969-e053-3a05fe0a2c94 1
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients, file e309ade0-3770-3969-e053-3a05fe0a2c94 1
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function., file e309ade0-4571-3969-e053-3a05fe0a2c94 1
null, file e309ade0-a4ec-3969-e053-3a05fe0a2c94 1
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells, file e309ade1-0db1-3969-e053-3a05fe0a2c94 1
How to improve effectiveness of pegvisomant treatment in acromegalic patients, file e309ade2-119d-3969-e053-3a05fe0a2c94 1
Functional hypothalamic and drug-induced amenorrhea: an overview, file e309ade2-3707-3969-e053-3a05fe0a2c94 1
Diagnostica differenziale tra forme monolaterali e bilaterali di iperaldosteronismo primario: il ruolo del cateterismo venoso selettivo delle vene surrenaliche, file e309ade2-b081-3969-e053-3a05fe0a2c94 1
Acromegaly in the elderly patients, file e309ade2-c9d7-3969-e053-3a05fe0a2c94 1
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major, file e309ade4-8ee7-3969-e053-3a05fe0a2c94 1
Densitometria Ossea (DEXA): come interpretarla evitando le trappole, file e309ade4-dcd7-3969-e053-3a05fe0a2c94 1
Correction to: Is the ghost of brown tumor back again? Features of hypercalcaemic primary hyperparathyroidism we must not forget (Endocrine, (2022), 75, 1, (306-308), 10.1007/s12020-021-02896-7), file e309ade4-e996-3969-e053-3a05fe0a2c94 1
Multidimensional geriatric evaluation in acromegaly: a comparative cross-sectional study, file e309ade5-0c84-3969-e053-3a05fe0a2c94 1
Malattia di Cushing e adenoma ipofisario multiclonale: la strana coppia, file e309ade5-1dee-3969-e053-3a05fe0a2c94 1
Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience, file e4d4639e-ff2e-45fc-b8f2-ccaf28193ee1 1
Totale 814
Categoria #
all - tutte 2271
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2271

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201923 0002 12 11 2365
2019/202048 5355 36 44 5332
2020/202199 3418 813 26 9121023
2021/2022233 1161616 2713 1716 10106031
2022/2023406 9317371 4031 6175 15000
Totale 814